NASDAQ: AXGNAxogen Inc Stock Ownership - Who owns Axogen?
Insider buying vs selling
Have Axogen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Amy Mcbride Wendell | Director | 2026-05-08 | 1,647 | $14.85 | $24.46kBuy |
| Amy Mcbride Wendell | Director | 2026-05-08 | 1,647 | $42.60 | $70.16kSell |
| Lindsey Marie Hartley | CFO | 2026-05-07 | 478 | $43.67 | $20.87kSell |
| Kathy Johnson Weiler | Director | 2026-05-07 | 16,344 | $44.09 | $720.62kSell |
| Kathy Johnson Weiler | Director | 2026-05-07 | 16,344 | $6.95 | $113.59kBuy |
| Doris Quackenbush | Sales VP | 2026-05-07 | 3,878 | $43.51 | $168.72kSell |
| Jens Kemp | Chief Marketing Officer | 2026-05-07 | 4,000 | $43.44 | $173.76kSell |
| Lindsey Marie Hartley | CFO | 2026-05-07 | 2,963 | $8.27 | $24.50kBuy |
| John Johnson | Director | 2026-05-07 | 11,050 | $43.26 | $477.97kSell |
| Lindsey Marie Hartley | CFO | 2026-05-07 | 573 | $43.67 | $25.02kSell |
AXGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AXGN insiders and whales buy or sell their stock.
AXGN Shareholders
What type of owners hold Axogen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Guido J. Neels | 15.64% | 8,318,965 | $362.87M | Insider |
| Joseph M. Mandato | 7.67% | 4,079,557 | $177.95M | Insider |
| First Light Asset Management LLC | 7.53% | 4,002,768 | $174.60M | Institution |
| Blackrock Inc | 7.28% | 3,870,851 | $168.85M | Institution |
| Ew Healthcare Partners LP | 6.98% | 3,711,111 | $161.88M | Insider |
| Morgan Stanley | 5.87% | 3,122,982 | $136.22M | Institution |
| James E. Flynn | 5.64% | 3,000,000 | $130.86M | Insider |
| De Novo Ventures II LP | 5.36% | 2,852,784 | $124.44M | Insider |
| Vanguard Capital Management LLC | 4.31% | 2,291,563 | $99.96M | Institution |
| Arrowmark Colorado Holdings LLC | 3.60% | 1,915,439 | $83.55M | Institution |
AXGN vs Medical Device Stocks
Axogen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.